BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marchi R, Sugita B, Centa A, Fonseca AS, Bortoletto S, Fiorentin K, Ferreira S, Cavalli LR. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review. Infect Genet Evol 2021;91:104832. [PMID: 33812037 DOI: 10.1016/j.meegid.2021.104832] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Ari Yuka S, Yilmaz A. Effect of SARS-CoV-2 infection on host competing endogenous RNA and miRNA network. PeerJ 2021;9:e12370. [PMID: 34722003 DOI: 10.7717/peerj.12370] [Reference Citation Analysis]
2 Hong BS, Kim MR. Interplays between human microbiota and microRNAs in COVID-19 pathogenesis: a literature review. Phys Act Nutr 2021;25:1-7. [PMID: 34315200 DOI: 10.20463/pan.2021.0008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Serpeloni JM, Lima Neto QA, Lucio LC, Ramão A, Carvalho de Oliveira J, Gradia DF, Malheiros D, Ferrasa A, Marchi R, Figueiredo DLA, Silva WA Jr, Ribeiro EMSF, Cólus IMS, Cavalli LR. Genome interaction of the virus and the host genes and non-coding RNAs in SARS-CoV-2 infection. Immunobiology 2021;226:152130. [PMID: 34425415 DOI: 10.1016/j.imbio.2021.152130] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Abusalah MAH, Khalifa M, Al-hatamleh MAI, Jarrar M, Mohamud R, Chan YY. Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm. JPM 2022;12:386. [DOI: 10.3390/jpm12030386] [Reference Citation Analysis]
5 Saha C, Laha S, Chatterjee R, Bhattacharyya NP. Co-Regulation of Protein Coding Genes by Transcription Factor and Long Non-Coding RNA in SARS-CoV-2 Infected Cells: An In Silico Analysis. Noncoding RNA 2021;7:74. [PMID: 34940755 DOI: 10.3390/ncrna7040074] [Reference Citation Analysis]
6 Nicoletti AS, Visacri MB, da Ronda CRDSC, Vasconcelos PEDNS, Quintanilha JCF, de Souza RN, Ventura DS, Eguti A, Silva LFS, Perroud Junior MW, Catharino RR, Reis LO, Dos Santos LA, Durán N, Fávaro WJ, Lancellotti M, da Costa JL, Moriel P, Pincinato EC. Differentially expressed plasmatic microRNAs in Brazilian patients with Coronavirus disease 2019 (COVID-19): preliminary results. Mol Biol Rep 2022. [PMID: 35301654 DOI: 10.1007/s11033-022-07338-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Liu X, Qiu H. Placenta-Derived Exosomes and Gestational Diabetes Mellitus. DMSO 2022;Volume 15:1391-404. [DOI: 10.2147/dmso.s363226] [Reference Citation Analysis]
8 Figueiredo DLA, Ximenez JPB, Seiva FRF, Panis C, Bezerra RDS, Ferrasa A, Cecchini AL, Medeiros AI, Almeida AMF, Ramão A, Boldt ABW, Moya CF, Chin CM, Paula D, Rech D, Gradia DF, Malheiros D, Venturini D, Tavares ER, Carraro E, Ribeiro EMSF, Pereira EM, Tuon FF, Follador FAC, Fernandes GSA, Volpato H, Cólus IMS, Oliveira JC, Rodrigues JHDS, Santos JLD, Visentainer JEL, Brandi JC, Serpeloni JM, Bonini JS, Oliveira KB, Fiorentin K, Lucio LC, Faccin-Galhardi LC, Ferreto LED, Lioni LMY, Consolaro MEL, Vicari MR, Arbex MA, Pileggi M, Watanabe MAE, Costa MAR, Giannini MJSM, Amarante MK, Khalil NM, Lima Neto QA, Herai RH, Guembarovski RL, Shinsato RN, Mainardes RM, Giuliatti S, Yamada-Ogatta SF, Gerber VKQ, Pavanelli WR, Silva WCD, Petzl-Erler ML, Valente V, Soares CP, Cavalli LR, Silva WA Jr. COVID-19: The question of genetic diversity and therapeutic intervention approaches. Genet Mol Biol 2021;44:e20200452. [PMID: 35421211 DOI: 10.1590/1678-4685-GMB-2020-0452] [Reference Citation Analysis]
9 Zhang Y, Chai Y, Hu Z, Xu Z, Li M, Chen X, Yang C, Liu J. Recent Progress on Rapid Lateral Flow Assay-Based Early Diagnosis of COVID-19. Front Bioeng Biotechnol 2022;10:866368. [PMID: 35592553 DOI: 10.3389/fbioe.2022.866368] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Bautista-Becerril B, Pérez-Dimas G, Sommerhalder-Nava PC, Hanono A, Martínez-Cisneros JA, Zarate-Maldonado B, Muñoz-Soria E, Aquino-Gálvez A, Castillejos-López M, Juárez-Cisneros A, Lopez-Gonzalez JS, Camarena A. miRNAs, from Evolutionary Junk to Possible Prognostic Markers and Therapeutic Targets in COVID-19. Viruses 2021;14:41. [PMID: 35062245 DOI: 10.3390/v14010041] [Reference Citation Analysis]
11 Lukiw WJ. microRNA Heterogeneity, Innate-Immune Defense and the Efficacy of SARS-CoV-2 Infection-A Commentary. Noncoding RNA 2021;7:37. [PMID: 34207055 DOI: 10.3390/ncrna7020037] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Dias TR, Dias F, Teixeira AL, Sousa H, Oliveira J, Medeiros R. MicroRNAs as Potential Tools for Predicting Cancer Patients’ Susceptibility to SARS-CoV-2 Infection and Vaccination Response. Cells 2022;11:2279. [DOI: 10.3390/cells11152279] [Reference Citation Analysis]
13 Parray A, Mir FA, Doudin A, Iskandarani A, Danjuma MM, Kuni RAT, Abdelmajid A, Abdelhafez I, Arif R, Mulhim M, Abukhattab M, Dar SR, Moustafa AA, Elkord E, Al Khal AL, Elzouki AN, Cyprian F. SnoRNAs and miRNAs Networks Underlying COVID-19 Disease Severity. Vaccines (Basel) 2021;9:1056. [PMID: 34696164 DOI: 10.3390/vaccines9101056] [Reference Citation Analysis]
14 Saulle I, Garziano M, Fenizia C, Cappelletti G, Parisi F, Clerici M, Cetin I, Savasi V, Biasin M. MiRNA Profiling in Plasma and Placenta of SARS-CoV-2-Infected Pregnant Women. Cells 2021;10:1788. [PMID: 34359957 DOI: 10.3390/cells10071788] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Ahmed JQ, Maulud SQ, Dhawan M, Priyanka, Choudhary OP, Jalal PJ, Ali RK, Tayib GA, Hasan DA. MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review. J Infect Public Health 2022;15:788-99. [PMID: 35751930 DOI: 10.1016/j.jiph.2022.06.012] [Reference Citation Analysis]
16 Haskologlu IC, Erdag E, Sayiner S, Abacioglu N, Sehirli AO. Melatonin and REGN-CoV2 combination as a vaccine adjuvant for Omicron variant of SARS-CoV-2. Mol Biol Rep 2022. [PMID: 35389130 DOI: 10.1007/s11033-022-07419-9] [Reference Citation Analysis]
17 Papanikolaou V, Chrysovergis A, Ragos V, Tsiambas E, Katsinis S, Manoli A, Papouliakos S, Roukas D, Mastronikolis S, Peschos D, Batistatou A, Kyrodimos E, Mastronikolis N. From delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants. Gene 2022;814:146134. [PMID: 34990799 DOI: 10.1016/j.gene.2021.146134] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 25.0] [Reference Citation Analysis]
18 Leite AOF, Bento Torres Neto J, Dos Reis RR, Sobral LL, de Souza ACP, Trévia N, de Oliveira RB, Lins NAA, Diniz DG, Diniz JAP, Vasconcelos PFDC, Anthony DC, Brites D, Picanço Diniz CW. Unwanted Exacerbation of the Immune Response in Neurodegenerative Disease: A Time to Review the Impact. Front Cell Neurosci 2021;15:749595. [PMID: 34744633 DOI: 10.3389/fncel.2021.749595] [Reference Citation Analysis]